Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03721796 · ClinicalTrials.gov registry record
Cancer Treatment Decision-making in the HIV Population: an Observational Study of Physician-patient Interactions
A clinical trial, sponsored by Duke University.
- Terminated
- Registry status
- 14
- Enrollment target
NCT03721796: Clinical Trial study, sponsored by Duke University.
NCT03721796 is a clinical trial that was terminated before completion, run by Duke University. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03721796 was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- 14 participants
- Enrollment target
Study Summary
This is a prospective, qualitative study consisting of observation and audio recording of the initial physician-patient consultations in newly diagnosed cancer patients occurring at the Duke University Medical Center (DUMC). Semi-structured debriefing interviews with participating oncologists and patients will follow the initial encounter.
Primary Outcome
The Physician Recommendation Coding System (PhyReCS) is a validated tool to measure the strength of physician recommendations using direct observation of clinical encounters. It is a global, 5-point scale ranging from -2 (strong recommendation against treatment) to +2 (strong recommendation for treatment) that captures how physicians portrayed treatment options during the entirety of the clinical appointment. The PhyReCS addresses major limitations with prior physician decision-making research b
Interventions
- OTHER Audio recording of initial consultation and debriefing interviews.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2019-05-26 |
| Est. Completion | 2020-03-16 |
Why NCT03721796 stopped before completion
NCT03721796 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Audio recording of initial consultation and debriefing interviews. is the first listed.
NCT03721796 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03721796 about?
NCT03721796 is a clinical study titled "Cancer Treatment Decision-making in the HIV Population: an Observational Study of Physician-patient Interactions". This is a prospective, qualitative study consisting of observation and audio recording of the initial physician-patient consultations in newly diagnosed cancer patients occurring at the Duke University Medical Center (DUMC). Semi-structured debriefing interviews with participating oncologists and pa...
What is the current status of trial NCT03721796?
This trial is currently terminated. The enrollment target is 14 participants. The study started on 2019-05-26. Estimated completion is 2020-03-16.
What interventions are being tested in trial NCT03721796?
The interventions under investigation include: Audio recording of initial consultation and debriefing interviews. (OTHER).
Who is sponsoring clinical trial NCT03721796?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy